Form 4: Establishment Labs Director Acquires Shares in Lieu of Cash Retainer

Director Ann Custin acquired 447 common shares of Establishment Labs Holdings Inc. (ESTA) on September 30, 2024, in lieu of a quarterly cash retainer payment.

Summary

• On September 30, 2024, Ann Custin, a director of Establishment Labs Holdings Inc. (ESTA), acquired 447 common shares.
• The shares were received in lieu of a quarterly cash retainer payment, as per the company's Outside Director Compensation Policy.
• The price per share was $43.27.
• Following the transaction, Custin directly owns 15,767 common shares.
• The shares were issued under the company's 2018 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director taking shares instead of cash is a mildly positive signal.

Positives

• A director's decision to take shares instead of cash may signal confidence in the company's future performance.

Industry Context

Directors receiving shares in lieu of cash compensation is a fairly common practice, particularly in growth-oriented companies, as it aligns their interests with those of shareholders.

Comparison to Industry Standards

• Comparing Establishment Labs' director compensation structure to companies like Sientra or Allergan (prior to its acquisition) could provide insights into whether this practice is standard within the medical aesthetics industry.
• Reviewing similar Form 4 filings from directors at comparable companies can reveal trends in equity compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates